Metabolically healthy obesity: a friend or foe?
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Obesity is associated with a reduced life expectancy, largely because obese individuals are at an increased risk of type 2 diabetes, cardiovascular disease, and several types of cancer. Much interest has recently focused on the concept of "all obesity is not created equally." Obese individuals without the metabolic abnormalities that commonly accompany excess adiposity, a condition known as metabolically healthy obesity (MHO), account for a substantial proportion of the obese adult population. Numerous possible mechanisms underlying MHO have been suggested, including adipose tissue distribution and inflammation. However, the prognostic value of MHO is controversial and considerably challenging. The lack of a standard definition for metabolic health and obesity as well as the dynamic properties of MHO may have contributed to these inconsistent results. This review aimed to present several current issues regarding MHO including its definition, epidemiology, natural course, suggested mechanisms, and clinical implications in the context of patient prognosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001
Mokdad, A. H., Ford, E. S., Bowman, B. A., Dietz, W. H., Vinicor, F., Bales, V. S., & Marks, J. S. (2003) · JAMA · doi:10.1001/jama.289.1.76 · Cited by 5,866 · cited 1×
“Obesity is associated with a reduced life expectancy, largely because obese individuals are at an increased risk of type 2 diabetes, cardiovascular disease (CVD), and several types of cancer [2].”
BackgroundGlobal burden of obesity in 2005 and projections to 2030
Kelly, T., Yang, W., Chen, C.-S., Reynolds, K., & He, J. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.102 · Cited by 3,319 · cited 1×
“The prevalence of obesity has increased worldwide over the past 30 years, making it a major public health concern [1].”
BackgroundDynamics of fat cell turnover in humans
Spalding, K. L., Arner, E., Westermark, P. O., Bernard, S., Buchholz, B. A., Bergmann, O., Blomqvist, L., Hoffstedt, J., Näslund, E., Britton, T., et al. (2008) · Nature · doi:10.1038/nature06902 · Cited by 2,357 · cited 1×
“These factors and their interactions lead to an expansion in fat mass because of an increase in the mean fat cell volume and the number of adipocytes [8,30].”
BackgroundWildman, R. P. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.15.1617 · Cited by 1,618 · cited 4×
“[18] suggested that MHO individuals were at an increased risk of mortality, regardless of the definition used, the different definitions make comparing findings, such as prevalence and long-term health effects, among studies difficult [14,19].”
BackgroundInfluentialEpidemic obesity and type 2 diabetes in Asia
Yoon, K.-H., Lee, J.-H., Kim, J.-W., Cho, J. H., Choi, Y.-H., Ko, S.-H., Zimmet, P., & Son, H.-Y. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69703-1 · Cited by 1,580 · cited 5×
“We recently demonstrated that 30.3% of the population in a health screening cohort were obese using body mass index (BMI) as the criteria (i.e., BMI ≥ 25 kg/m2) and nearly half (55.2”
BackgroundInfluentialIdentification and characterization of metabolically benign obesity in humans
Stefan, N. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.15.1609 · Cited by 1,049
The metabolically obese, normal-weight individual revisited.
Ruderman, N., Chisholm, D., Pi-Sunyer, X., & Schneider, S. (1998) · Diabetes · doi:10.2337/diabetes.47.5.699 · Cited by 893
Metabolically healthy obesity: Epidemiology, mechanisms, and clinical implications
Stefan, N., Häring, H.-U., Hu, F. B., & Schulze, M. B. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70062-7 · Cited by 857
A proposed clinical staging system for obesity
Sharma, A. M., & Kushner, R. F. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.2 · Cited by 687 · cited 1×
“BMI alone or any anthropometric markers of adiposity do not provide measurements of functionality, quality of life, or other prognostic contextual factors that may further characterize the clinical risk and guide clinical management [6,73].”
Background
Cited by
Cӑtoi, A. F., Pârvu, A. E., Andreicuț, A. D., Mironiuc, A., Crӑciun, A., Cӑtoi, C., & Pop, I. D. (2018) · Nutrients · doi:10.3390/nu10091199 · Cited by 78
“However, Gomez et al. [18] revealed that circulating concentrations of pro-inflammatory parameters such as CRP are similarly increased in both MHO and MUHO.”
BackgroundInfluentialDiMenna, F. J., & Arad, A. D. (2018) · BMC Sports Science, Medicine and Rehabilitation · doi:10.1186/s13102-018-0110-8 · Cited by 68
Bays, H. E., Golden, A., & Tondt, J. (2022) · Obesity Pillars · doi:10.1016/j.obpill.2022.100034 · Cited by 34
Metadata
- Authors
- Jung, C. H., Lee, W. J., & Song, K.-H.
- Venue
- The Korean Journal of Internal Medicine
- Published
- 2017-07-01
- Volume
- 32
- Issue
- 4
- Pages
- 611-621
- ISSN
- 1226-3303 (ISSN-L)
- 2005-6648
- OpenAlex
- W2621944419
- Cited by
- 139
- References
- 14
- FWCI
- 10.95
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Metabolically healthy obesity: a friend or foe? https://app.cochat.ai/papers/10.3904/kjim.2016.259
- The paper
- Jung, C. H., Lee, W. J., & Song, K.-H. (2017). Metabolically healthy obesity: a friend or foe? The Korean Journal of Internal Medicine. https://doi.org/10.3904/kjim.2016.259
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.